Skip to main content
KAMADA LTD logo

KAMADA LTD — Investor Relations & Filings

Ticker · KMDA US Manufacturing
Open in API
Filings indexed 447 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country US United States of America
Listing US KMDA

About KAMADA LTD

https://www.kamada.com/

Kamada Ltd. is a vertically integrated global biopharmaceutical company focused on specialty plasma-derived therapeutics. The company engages in the research, development, manufacturing, and commercialization of protein therapeutics derived from human plasma. It utilizes a proprietary platform technology for protein extraction and purification to address rare and serious conditions. Key therapeutic areas include Alpha-1 Antitrypsin Deficiency (AATD), with a development pipeline featuring an inhaled AAT therapy, and the prevention of Cytomegalovirus (CMV) disease in transplant recipients. The company's operations also encompass the collection of human plasma through its U.S.-based subsidiary.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 86% confidence The document is a Form 6-K filed by a foreign private issuer to the U.S. SEC, providing a brief report and an attached exhibit. It does not contain detailed financial statements or qualify as an Annual or Interim Report, nor is it an earnings release or management presentation. As a miscellaneous regulatory submission by a foreign issuer, it falls under the general regulatory filings category.
2026-06-01 English
6-K - KAMADA LTD (0001567529) (Filer)
Regulatory Filings Classification · 96% confidence The document is a Form 6-K filed under the Securities Exchange Act by a foreign private issuer (Kamada Ltd.). It is a regulatory submission to the SEC listing attached exhibits (quarterly results, presentation, XBRL exhibits) rather than the substantive financial report itself. Therefore it falls under the general “Regulatory Filings” category (RNS) as a fallback for miscellaneous compliance filings.
2026-05-13 English
6-K - KAMADA LTD (0001567529) (Filer)
Regulatory Filings Classification · 90% confidence The document is a Form 6-K (“Report of Foreign Private Issuer”) filed with the SEC by Kamada Ltd. It does not itself contain financial statements or management discussion but is a regulatory submission under the Securities Exchange Act. It merely attaches an exhibit announcing the upcoming Q1 results. This is a general regulatory announcement/fallback filing, fitting the “Regulatory Filings” category (RNS).
2026-05-06 English
6-K - KAMADA LTD (0001567529) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It is not an annual report (10-K) or quarterly report (IR), but rather a periodic report for foreign companies. The content specifically mentions an update on withholding tax procedures related to a previously announced cash dividend. The document length is short (2002 characters), and it primarily serves as an announcement or update rather than a full financial report. It does not contain detailed financial statements or comprehensive management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-03-31 English
6-K - KAMADA LTD (0001567529) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC under the Securities Exchange Act of 1934. It is not an annual report (like 10-K or 20-F), nor does it contain detailed financial statements or management discussion. The content includes an announcement about FDA approval of a plasma collection center, which is a regulatory or operational update rather than a financial report. The document length is short (1900 characters), and it primarily serves as a regulatory filing to inform the market of a material event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2026-03-26 English
3 - KAMADA LTD (0001567529) (Issuer)
Director's Dealing
2026-03-23 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.